18 reports

  • Killing of Bacteria Encased in Biofilm In Vitro" on Sept 13th at the 53rd annual ICAAC Meeting.

It acts by targeting fibroblast growth factor-## (FGF-##).

  • Pharmaceutical
  • Therapy
  • Type 2 Diabetes
  • Wound Care
  • ProMetic Life Sciences Inc.

In October 2006, Lakewood-Amedex Inc. filed a patent with (US ##/ ##, ##) entitled " Antimicrobial and antiviral compounds and methods for their use".

  • Chronic Disease
  • Therapy
  • Type 2 Diabetes
  • Wound Care
  • ViroMed Co., Ltd.

The molecules developed by Companies in Phase III, IND/ CTA Filed, Preclinical, Discovery and Unknown stages are ##, ##, ##, ## and ## respectively.

  • Pharmaceutical
  • Therapy
  • Wound Care
  • United States
  • Product Initiative

ONE UNIT REFERS TO ONE SPECIALTY BED.

  • Mattress
  • Wound Care
  • Canada
  • North America
  • Market Size

The prominent features of this report are - ##.

  • Cancer Hormonal Therapy
  • Clinical Trial
  • Drug Development
  • World
  • Product Initiative

It offers products in the therapeutic areas of oncology, hematology, immune diseases, antibiotics, antivirals, neurology, cardiology, multiple sclerosis, hemophilia and diabetes, among others.

  • Cancer Hormonal Therapy
  • Wound Care
  • United States
  • Product Initiative
  • Alnylam Pharmaceuticals, Inc.

It offers products in the therapeutic areas of oncology, hematology, immune diseases, antibiotics, antivirals, neurology, cardiology, multiple sclerosis, hemophilia and diabetes, among others.

  • Cancer Hormonal Therapy
  • Endocrine Disease
  • Therapy
  • Wound Care
  • Alnylam Pharmaceuticals, Inc.

The trial will be a randomized (##:##), placebo-controlled, double-blind study.

  • Cancer Hormonal Therapy
  • Hepatitis
  • World
  • Product Initiative
  • Pfizer Inc.

Exportin ## (Chromosome Region Maintenance ## Protein Homolog or XPO##) - Overview EXPORTIN ## (XPO##) OR CHROMOSOMAL MAINTENANCE ## (CRM##) IS A EUKARYOTIC PROTEIN.

  • Cancer
  • Cancer Hormonal Therapy
  • United States
  • Product Initiative
  • Karyopharm Therapeutics Inc.

Target ## Target ## Acquirer KCI USA, Inc.

  • Wound Care
  • United States
  • Company
  • Corporate Finance
  • KCI

Target ## Target ## Acquirer KCI USA, Inc.

  • Wound Care
  • United States
  • Company
  • Corporate Finance
  • KCI

The company offers API' s and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, betalactase inhibitors, PEGlyated compounds and anti-histamines.

  • Wound Care
  • United States
  • World
  • Product Initiative
  • RXi Pharmaceuticals Corporation

Target ## Target ## Acquirer KCI USA, Inc.

  • Wound Care
  • United States
  • Company
  • Corporate Finance
  • KCI

CLINICAL TRIAL PROFILE SNAPSHOTS Note: ##.

  • Blood Disease
  • Cancer Hormonal Therapy
  • Clinical Trial
  • Targeted Therapy
  • World

The company offers API' s and intermediates for antibiotic, antiviral, antifungal, anti-inflammatory, anti-diabetic, anti-HIV, anti-HCV, betalactase inhibitors, PEGlyated compounds and anti-histamines.

  • Wound Care
  • United States
  • World
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • Wounds - Companies Involved in Therapeutics Development

Tolecine is an anti-tumor LCP (liquid crystal pharmaceutical) that also has antiviral and antibacterial applications.

  • Medical Supply
  • Wound Care
  • United States
  • Company
  • Product Initiative
  • SYNTHETIC PEPTIDES TO ANTAGONIZE TGF-BETA RECEPTOR FOR DIABETIC FOOT ULCERS, PULMONARY FIBROSIS AND DERMATOLOGY - DRUG PROFILE

Tolecine is an anti-tumor LCP (liquid crystal pharmaceutical) that also has antiviral and antibacterial applications.

  • Healthcare
  • Type 2 Diabetes
  • Wound Care
  • United States
  • Product Initiative

One unit refers to one semi-permeable film dressing.

  • Hospital
  • Wound Care
  • United States
  • Company
  • Covalon Technologies Ltd.